AlgoSurg
Healthcare Software · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1013 Centre Rd Ste 403B, Wilmington, Del...Website
www.algosurg.aiRevenue
<$5 MillionIndustry
About AlgoSurg
AlgoSurg Org Chart
Is AlgoSurg your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AlgoSurg recently announced quarterly report
Product Launch: Get notified when AlgoSurg launches new products
Congratulate Masked Content for being promoted to Masked Content at AlgoSurg
Check if AlgoSurg has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AlgoSurg, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once AlgoSurg has new funding data
Website visits: Recent activity has been detected on your website
Check out if AlgoSurg is spiking on competitors!
Click to see if AlgoSurg had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at AlgoSurg
Find 2 more new buyers
Company Profile Activity
Activity Insights
AlgoSurg is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
AlgoSurg is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about AlgoSurg.
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AlgoSurg
AlgoSurg is transforming surgical planning through AI-powered automation and robotic surgery solutions, enhancing precision and efficiency for medical device companies. Their advanced technology streamlines workflows, making robotic surgeries faster and smarter while also automating 3D printing processes. The company collaborates with partners in t... Read More